This author has yet to write their bio.Meanwhile lets just say that we are proud Reuters Health contributed a whooping 7497 entries.
The World Health Organization has added new curative treatments for hepatitis C to its essential medicines list, but the U.N. agency said prices needed to fall to make them accessible […]
Swiss drugmaker Novartis said European health regulators have approved a drug for advanced lung cancer that is intended to treat patients with a specific genetic mutation. Zykadia, or ceritinib, is […]
Vertex Pharmaceuticals Inc’s combination of an experimental compound and an approved drug significantly improved lung function in cystic fibrosis patients with the most common genetic mutation underlying the disease, FDA […]
Generics drugmaker Mylan NV (MYL.O), which is in the middle of a three-way takeover battle, has said it is unwilling to sell itself to Israeli rival Teva Pharmaceuticals Industries Ltd […]
(Reuters) – German chemicals group BASF (BASFn.DE) has agreed to sell parts of its pharmaceutical ingredients business to Swiss drug contract manufacturer Siegfried Holding (SFZN.S) for 270 million euros ($306 […]
(Reuters) – Swiss drugmaker Roche said on Thursday the U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation for venetoclax for the treatment of people who have relapsed […]
A diabetic tests his blood sugar level in Vienna November 13, 2012. Picture taken November 13. Reuters/Heinz-Peter Bader (Reuters Health) – Intensive medical management with supervised diet and exercise may […]
(Reuters) – Celgene Corp on Thursday said the European Patent Office revoked a key patent on the company’s flagship multiple myeloma drug Revlimid, a move that could shave a year […]
(Reuters) – The measles vaccine provides benefits beyond merely protecting against that highly contagious viral respiratory disease that remains a leading childhood killer in parts of the world, scientists say. […]
LONDON (Thomson Reuters Foundation) – Fake and low-quality drugs hinder efforts to tackle disease, weaken public trust in national health systems and raise questions over governance, drug researchers said […]
